Dong-A ST and iSense signed a sales contract for Caresense Air experts with continuous blood glucose meter
|
The agreement, which was held at Dong-A ST's headquarters in Yongdu-dong, Dongdaemun-gu, Seoul on October 21, was signed to provide a more precise and efficient blood sugar management solution in the medical field by combining Dong-A ST's hospital and medical institution sales network and ISEN's blood sugar measurement technology.
Under the agreement, ISEN will supply Caresen Air specialists to Dong-A ST. Dong-A ST distributes Caresense Air experts to domestic hospitals and clinics and conducts sales and marketing activities.
CareSense Air, a continuous blood glucose meter from iSense, a manufacturer specializing in diagnostic medical devices, attaches a sensor to the skin to measure changes in blood glucose for 24 hours consecutively for up to 15 days. The measured data can be shared and managed by medical staff, patients, and guardians through a smartphone app, and the rise and fall trends and patterns of blood sugar can be identified in real time, providing information on blood sugar fluctuations that are difficult to confirm with existing autologous glucose meters or glycated hemoglobin tests.
Care Sense Air specialists exclusively for hospitals and clinics are domestic continuous blood glucose meters that are recognized for the cost of reading test results even for type 2 diabetes, supplementing the limitations of non-payment of existing personal continuous blood glucose meters. The personal continuous blood glucose meter can check blood sugar on its own, so temporary behavioral changes can cause blood sugar fluctuations that are different from the actual ones. On the other hand, a continuous blood glucose meter for experts is designed to limit the ability to check blood sugar to collect actual blood sugar patterns that are not distorted during the patient's daily life. Through this, medical staff can more accurately analyze blood sugar fluctuations according to the patient's actual lifestyle and establish customized treatment strategies.
Chairman of ISense, Step-Sik said, "This agreement will be a turning point in providing a more precise and efficient blood sugar management solution in the medical field by synergy between ISense's independent continuous blood sugar meter technology and Dong-A ST's solid network of hospitals and clinics."IceSense will continue to set new standards for diabetes management at home and abroad through continuous technological innovation and global market expansion."," he stressed.
Jung Jae-hoon, President of Dong-A ST, said "The market for continuous blood glucose meters is growing rapidly at home and abroad, and products for Caresense Air professionals are receiving high attention in the medical field."We will strengthen cooperation with iSense to contribute to the expansion of the spread of continuous blood glucose meters and the improvement of patients' quality of life."
This article was translated by Naver AI translator.
